XML 68 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value  
Schedule of assets and liabilities measured at fair value on a recurring basis

    

Fair Value Measurements as of December 31, 2022

Quoted Prices in

Significant

Active Markets for

Other

Significant

Identical Assets

Observable

Unobservable

(dollars in thousands)

  

(Level 1)

  

Inputs (Level 2)

  

Inputs (Level 3)

  

Total

Assets

U.S. Treasury and government agency debt securities

$

$

150,982

$

$

150,982

Government-sponsored enterprises debt securities

44,301

44,301

Mortgage-backed securities:

Residential - Government agency(1)

59,723

59,723

Residential - Government-sponsored enterprises(1)

1,160,455

1,160,455

Commercial - Government agency

237,853

237,853

Commercial - Government-sponsored enterprises

119,573

119,573

Commercial - Non-agency

21,471

21,471

Collateralized mortgage obligations:

Government agency

653,322

653,322

Government-sponsored enterprises

462,132

462,132

Collateralized loan obligations

241,321

241,321

Total available-for-sale securities

3,151,133

3,151,133

Other assets(2)

5,376

10,945

16,321

Liabilities

Other liabilities(3)

(49,268)

(851)

(50,119)

Total

$

5,376

$

3,112,810

$

(851)

$

3,117,335

    

Fair Value Measurements as of December 31, 2021

Quoted Prices in

Significant

Active Markets for

Other

Significant

Identical Assets

Observable

Unobservable

(dollars in thousands)

  

(Level 1)

  

Inputs (Level 2)

  

Inputs (Level 3)

  

Total

Assets

U.S. Treasury and government agency debt securities

$

$

192,563

$

$

192,563

Mortgage-backed securities:

Residential - Government agency(1)

137,264

137,264

Residential - Government-sponsored enterprises(1)

1,491,100

1,491,100

Commercial - Government agency

387,663

387,663

Commercial - Government-sponsored enterprises

1,369,443

1,369,443

Collateralized mortgage obligations:

Government agency

2,079,523

2,079,523

Government-sponsored enterprises

2,621,044

2,621,044

Collateralized loan obligations

105,247

105,247

Debt securities issued by states and political subdivisions

44,185

44,185

Total available-for-sale securities

8,428,032

8,428,032

Other assets(2)

7,382

50,925

58,307

Liabilities

Other liabilities(3)

(1,238)

(5,530)

(6,768)

Total

$

7,382

$

8,477,719

$

(5,530)

$

8,479,571

(1)Backed by residential real estate.
(2)Other assets classified as Level 1 include mutual funds and money market funds that have quoted prices in active markets and are related to the Company’s deferred compensation plans. Other assets classified as Level 2 include derivative assets.
(3)Other liabilities include derivative liabilities.

Summary of changes in Level 3 liabilities measured at fair value on a recurring basis

Visa Derivative

(dollars in thousands)

2022

  

2021

Year Ended December 31, 

Balance as of January 1,

$

(5,530)

$

(4,554)

Total net losses included in other noninterest income

(707)

(5,909)

Settlements

5,386

4,933

Balance as of December 31, 

$

(851)

$

(5,530)

Total net losses included in net income attributable to the change in unrealized losses related to liabilities still held as of December 31, 

$

(707)

$

(5,909)

Summary of estimated fair value of financial instruments not required to be carried at fair value on a recurring basis

December 31, 2022

Fair Value Measurements

Quoted Prices in

Significant

Significant

Active Markets

Other

Unobservable

for Identical

Observable

Inputs

(dollars in thousands)

  

Book Value

  

Assets (Level 1)

  

Inputs (Level 2)

  

(Level 3)

  

Total

Financial assets:

Cash and cash equivalents

$

526,624

$

297,502

$

229,122

$

$

526,624

Investment securities held-to-maturity

4,320,639

3,814,822

3,814,822

Loans(1)

13,793,922

13,138,787

13,138,787

Financial liabilities:

Time deposits(2)

$

2,476,050

$

$

2,423,231

$

$

2,423,231

Short-term borrowings

75,000

74,991

74,991

December 31, 2021

Fair Value Measurements

Quoted Prices in

Significant

Significant

Active Markets

Other

Unobservable

for Identical

Observable

Inputs

(dollars in thousands)

  

Book Value

  

Assets (Level 1)

  

Inputs (Level 2)

  

(Level 3)

  

Total

Financial assets:

Cash and cash equivalents

$

1,258,469

$

246,716

$

1,011,753

$

$

1,258,469

Loans held for sale

538

542

542

Loans(1)

12,730,605

12,791,811

12,791,811

Financial liabilities:

Time deposits(2)

$

1,776,438

$

$

1,773,321

$

$

1,773,321

(1)Excludes financing leases of $298.1 million at December 31, 2022 and $231.4 million at December 31, 2021.
(2)Excludes deposit liabilities with no defined or contractual maturity of $19.2 billion at December 31, 2022 and $20.0 billion at December 31, 2021.

Significant unobservable inputs used in fair value measurements for Level 3 assets and liabilities measured at fair value on a recurring basis

Quantitative Information about Level 3 Fair Value Measurements at December 31, 2022

Significant

(dollars in thousands)

Fair value

  

Valuation Technique

  

Unobservable Input

  

Range

Visa derivative

$

(851)

Discounted Cash Flow

Expected Conversion Rate - 1.5991(1)

1.5514-1.5991

Expected Term - 3 months(2)

0 - 6 months

Growth Rate - 26%(3)

10% - 38%

Quantitative Information about Level 3 Fair Value Measurements at December 31, 2021

Significant

(dollars in thousands)

Fair value

  

Valuation Technique

  

Unobservable Input

  

Range

Visa derivative

$

(5,530)

Discounted Cash Flow

Expected Conversion Rate - 1.6181(1)

1.5885-1.6181

Expected Term - 1 year(4)

0.5 to 1.5 years

Growth Rate - 26%(3)

10% - 38%

(1)Due to the uncertainty in the movement of the conversion rate, the current conversion rate as of the respective consolidated balance sheet dates was utilized in the fair value calculation.
(2)The expected term of 3 months was based on the median of 0 to 6 months.
(3)The growth rate was based on the arithmetic average of analyst price targets.
(4)The expected term of 1 year was based on the median of 0.5 to 1.5 years.